Vitamin d supplements ‘do not’ reduce colds in asthma patients

Vitamin d supplements ‘do not’ reduce colds in asthma patients


Play all audios:

Loading...

Taking vitamin D supplements does not reduce the number or severity of colds experienced by asthma patients, according to a US study. The findings surprised the researchers who in a previous


study had found a 40% reduction in asthma exacerbations in patients with a vitamin D deficiency who achieved normal levels with supplements. > “We can’t recommend vitamin D for the 


prevention of colds” >  > Loren Denlinger Because colds often trigger exacerbations, they had hypothesized that vitamin D supplementation would reduce colds and cold severity. Study


author Dr Loren Denlinger, associate professor of medicine at the University of Wisconsin, said: “Other studies of vitamin D and colds have produced mixed results. Most of those studies were


conducted among healthy patients. “We wanted to ask the same question of a patient population in which the impact of a cold carries greater risk,” she said. The researchers followed asthma


patients who were undergoing inhaled corticosteroid (ICS) “tapering” to test the hypothesis that vitamin D might bolster the potency of the ICS. The trial involved 408 adults with


mild-to-moderate asthma whose vitamin D levels were insufficient or deficient. Study participants had asthma symptoms, despite low-dose ICS therapy. The patients were randomised to receive


either vitamin D supplementation (100,000 IU once, then 4,000 IU daily) or placebo for 28 weeks. vitamins During that time, about half the participants experienced at least one cold, said


the study authors in the _American Journal of Respiratory and Critical Care Medicine_. The researchers analysed separately the results of the 82% of participants receiving supplements who


achieved vitamin D sufficiency within 12 weeks. Achieving sufficiency made no difference in number of colds or their severity the group experienced, they said. ”In patients with


mild-to-moderate asthma undergoing an ICS dose-reduction, these results do not support the use of vitamin D supplementation for the purpose of reducing cold severity or frequency,” they


stated in the journal.  “We can’t recommend vitamin D for the prevention of colds,” added Dr Denlinger. The researchers suggested one explanation for the finding was that asthma patients


with low vitamin D levels may be more likely to experience upper respiratory infections asymptomatically than those with normal levels of vitamin D – known to trigger an inflammatory


response. The inflammatory response may, in turn, reduce the risk of lower airway infections, which are triggers for asthma exacerbations, they said.